I agree; moreover, the typical equipose that underlies unblinding/crossover does not pertain in this trial. The placebo patients do not have any disease when they enter the trial, and they presumably wouldn’t be helped by subsequent vaccination if they develop COVID-19 during the trial.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.